Top Markets
#1 Seeker Seeker +18.80%
#2 EXOD EXOD +9.04%
#3 Wrapped Aave Ethereum WETH Wrapped Aave Ethereum WETH +7.47%
#4 Arowana Arowana +5.88%
#5 MetaDAO MetaDAO +4.67%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +4.02%
#7 Mina Protocol Mina Protocol +3.88%
#8 Pons Pons +3.00%
#9 Solstice Solstice +2.88%
#10 Official Trump Official Trump +2.75%
Coin of the day
Seeker Seeker
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Alpine Immune Sciences, Inc. Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc.

ALPN
Clasificación en acciones #6581
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company... Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and advancing protein-based immunotherapies. Their therapeutic endeavors address a range of conditions, including various cancers, autoimmune and inflammatory disorders, among others. The company's pipeline features ALPN-101, an ICOS/CD28 antagonist program being developed for autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor aimed at treating cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated inflammatory and autoimmune conditions. Alpine Immune Sciences has established strategic collaborations, including an agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101, and a partnership with Adaptimmune Therapeutics plc to create next-generation SPEAR T cell products. The company was founded in 2007 and operates from its headquarters in Seattle, Washington.
Precio por acción
$64.97
Última sincronización: 2024-05-20
Capitalización bursátil
$1.97B
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio Alpine Immune Sciences, Inc. (ALPN)

Categoría

Healthcare
Ratio P/B de Alpine Immune Sciences, Inc. (ALPN)
Ratio P/B al August 2026 TTM: 9.91
Según los informes financieros más recientes y el precio de las acciones de Alpine Immune Sciences, Inc., el ratio P/B actual (TTM) es 9.91. Al final de 2022, el ratio P/B era 1.37.
Historial del ratio P/B de Alpine Immune Sciences, Inc. desde 2012 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
2026 (TTM) 9.91 240.41%
2023 2.91 112.16%
2022 1.37 -53.07%
2021 2.92 -30.87%
2020 4.22 76.50%
2019 2.39 109.27%
2018 1.14 24.25%
2017 0.92 46.95%
2016 0.63 -27.94%
2015 0.87 -110.05%
2014 -8.64 479.51%
2013 -1.49 0.00%
2012 0.00 0.00%
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -35.98%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -36.99%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -74.71%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -62.56%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH